4-Chloro-6,7-dimethoxyquinazolin-2-amine is primarily used in the field of medicinal chemistry as a key intermediate in the synthesis of various biologically active compounds. It serves as a building block for the development of kinase inhibitors, which are crucial in targeting specific enzymes involved in cell signaling pathways. These inhibitors have potential applications in treating cancers and other diseases where abnormal kinase activity plays a role. Additionally, the compound is utilized in research to explore its pharmacological properties and to design new therapeutic agents with improved efficacy and selectivity. Its structural features make it a valuable scaffold for drug discovery efforts aimed at addressing unmet medical needs.